Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

por Randi Hagerman, Sebastien Jacquemont, Elizabeth Berry-Kravis, Vincent Des Portes, Andrew Stanfield, Barbara Koumaras, Gerd Rosenkranz, Alessandra Murgia, Christian Wolf, George Apostol, Florian von Raison
Publicado 2018